MERCURY LABORATORIES
Back to Balance Sheet
|
MERCURY LABORATORIES Last 5 Year Total Current Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹16 Cr | ₹16 Cr | ₹19 Cr | ₹15 Cr | ₹17 Cr |
What is the latest Total Current Liabilities ratio of MERCURY LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹16 Cr |
Mar2022 | ₹16 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹15 Cr |
Mar2019 | ₹17 Cr |
How is Total Current Liabilities of MERCURY LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹16 Cr | 4.32 | |
Mar2022 | ₹16 Cr | -16.39 | |
Mar2021 | ₹19 Cr | 25.02 | |
Mar2020 | ₹15 Cr | -10.95 | |
Mar2019 | ₹17 Cr | - |
Compare Total Current Liabilities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹124.1 Cr | -1.7% | 5.8% | 23.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹447,596.0 Cr | 0.1% | 6.6% | 60.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,695.0 Cr | -0.5% | 11% | 42.5% | Stock Analytics | |
CIPLA | ₹132,401.0 Cr | -1.2% | 3.4% | 32.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,341.0 Cr | -1.4% | -6% | 11.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,198.0 Cr | -5.4% | -12.8% | 63.3% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -1.7% |
5.8% |
23.5% |
SENSEX | 2% |
4.5% |
25.2% |
You may also like the below Video Courses